Generic drugmaker Natco Pharma consolidated net profit surged 83% to ₹676.5 crore for the quarter ended September, from ₹369 ...

Natco Pharma on November 12 said its consolidated net profit jumped 83 percent on-year to Rs 676 crore in the September 2024 ...

Natco Pharma on Tuesday said its consolidated net profit jumped 83 per cent on-year to Rs 676 crore in the September 2024 ...

Dividend: Second interim dividend of INR1.5 per equity share for FY24-25. Natco Pharma Ltd (BOM:524816) reported a 35.3% increase in consolidated total revenue for Q2 FY25 compared to the same period ...

Natco Pharma has announced an 83 percent on-year increase in its consolidated net profit for the September 2024 quarter, ...

Natco Pharma reports 83% increase in net profit, 35% growth in revenue, declares second interim dividend for FY2024-25.

Natco Pharma Q2 Results Live : Natco Pharma announced its Q2 results on November 12, 2024, revealing a significant growth in ...

Natco Pharma’s board declared a second interim dividend of ₹1.50 per equity share, with a face value of ₹2, for FY 2024-25.

Natco Pharma rose 1.00% to Rs 1,409.70 after the company's consolidated net profit surged 83.55% to Rs 677.30 crore in Q2 FY25 as against Rs 369 crore reported in Q2 FY24.

Indian pharma opts for ELNs to streamline research, improve compliance and accelerate innovation: Nandita Vijayasimha, Bengaluru Friday, November 15, 2024, 08:00 Hrs [IST] Indian ...

Natco Pharma's net profit soared 83% YoY to Rs 676 crore in Q2 FY25, driven by strong sales growth. Revenue also increased significantly, with exports and domestic businesses performing well. New ...

NEW DELHI: The Nifty Pharma index traded negative around 10:53AM(IST)on Wednesday in a weak market. Natco Pharma Ltd.(up 2.46 ...